These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 17587812)

  • 1. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
    Bagnato A; Rosanò L
    Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
    Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
    Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression.
    Rosanò L; Spinella F; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1128-31. PubMed ID: 16741062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
    Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of the endothelin axis in ovarian tumor progression.
    Bagnato A; Spinella F; Rosanò L
    Endocr Relat Cancer; 2005 Dec; 12(4):761-72. PubMed ID: 16322321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
    Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
    Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
    Hsu YM; Chen YF; Chou CY; Tang MJ; Chen JH; Wilkins RJ; Ellory JC; Shen MR
    Cancer Res; 2007 Nov; 67(22):11064-73. PubMed ID: 18006853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
    Ghoul A; Serova M; Astorgues-Xerri L; Bieche I; Bousquet G; Varna M; Vidaud M; Phillips E; Weill S; Benhadji KA; Lokiec F; Cvitkovic E; Faivre S; Raymond E
    Cancer Res; 2009 May; 69(10):4260-9. PubMed ID: 19417139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
    Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of the endothelin a receptor in human ovarian carcinoma.
    Rosanò L; Spinella F; Salani D; Di Castro V; Venuti A; Nicotra MR; Natali PG; Bagnato A
    Cancer Res; 2003 May; 63(10):2447-53. PubMed ID: 12750265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZD4054, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma cell proliferation.
    Rosanò L; Di Castro V; Spinella F; Decandia S; Natali PG; Bagnato A
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1132-5. PubMed ID: 16741063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.
    Yang AD; Camp ER; Fan F; Shen L; Gray MJ; Liu W; Somcio R; Bauer TW; Wu Y; Hicklin DJ; Ellis LM
    Cancer Res; 2006 Jan; 66(1):46-51. PubMed ID: 16397214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
    Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma.
    Rosanò L; Spinella F; Di Castro V; Dedhar S; Nicotra MR; Natali PG; Bagnato A
    Mol Cancer Ther; 2006 Apr; 5(4):833-42. PubMed ID: 16648553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.
    Rosanò L; Varmi M; Salani D; Di Castro V; Spinella F; Natali PG; Bagnato A
    Cancer Res; 2001 Nov; 61(22):8340-6. PubMed ID: 11719468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-mesenchymal transition in ovarian cancer.
    Vergara D; Merlot B; Lucot JP; Collinet P; Vinatier D; Fournier I; Salzet M
    Cancer Lett; 2010 May; 291(1):59-66. PubMed ID: 19880243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.
    Larue L; Bellacosa A
    Oncogene; 2005 Nov; 24(50):7443-54. PubMed ID: 16288291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.
    Zhang W; Jiang B; Guo Z; Sardet C; Zou B; Lam CS; Li J; He M; Lan HY; Pang R; Hung IF; Tan VP; Wang J; Wong BC
    Carcinogenesis; 2010 Jul; 31(7):1220-9. PubMed ID: 20460358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.